The objective of this study was to examine the association of alcohol drinking and lipid profile with infrarenal aortic dimension. The diameter of the infrarenal aorta was measured using ultrasound in 395 individuals (mean 66.6 ± 10.3 years) with atherosclerotic diseases or risk factors. The associations between heavy drinking, serum lipoprotein (a) levels, lipid profile and infrarenal aorta diameters were examined. Heavy drinking and lipoprotein (a) were positively related with infrarenal aortic dimension, while low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C), LDL-C and total cholesterol (TC)/HDL-C were negatively associated with infrarenal aortic diameter (p < 0.05). In addition, there were negative associations of LDL-C/HDL-C, TC/HDL-C and positive associations of HDL-C and apolipoprotein AI (Apo AI) with heavy drinking (p < 0.05). In conclusion, there was a positive association between infrarenal aortic diameters and heavy drinking, as well as lipoprotein (a) levels. Furthermore, the novel and unexpected inverse association between LDL-C/HDL-C, LDL-C, TC/HDL-C and abdominal aortic diameter may suggest a possible role for antiatherogenic lipid profile (characterized by a higher level of HDL-C and lower level of LDL-C) in aortic dilatation processes, which need to be clarified by further studies.
Introduction
Infrarenal aortic diameter is central to the diagnosis of abdominal aortic aneurysm (AAA). Studies of patients with AAAs have shown that morbidity increases with aneurysmal diameter. 1 Furthermore, in a previous population-based follow-up study, Norman et al. demonstrated that there was an independent graded relationship between aortic diameter and all-cause mortality for the whole range of diameter values, not just those in the aneurysmal range (≥30 mm in diameter). 2 Similarly, in a more recent investigation, infrarenal aortic diameters >2.0 cm were found to be associated with a significantly increased risk of future cardiovascular disease (CVD) events (defined as coronary heart disease, congestive heart failure, transient ischemic attack or stroke, claudication, and atherosclerotic coronary heart disease) and total mortality. 3 However, there are limited studies on the epidemiology of aortic diameter. [4] [5] [6] Risk factors and potential alternative pathomechanisms for the development of infrarenal aortic dilatation need to be further explored.
It was recently reported that local calcified atherosclerosis in the abdominal aorta is associated with increasing aortic diameter. 6 Although high lipid levels are known to be related to the development of atherosclerosis, results of previous studies on the association between abdominal aortic diameter and lipid profile have been inconsistent. 5, 6 Jian-an Wang and Xiao-feng Chen contributed equally to this work.
Lipoprotein (a) [Lp(a)] is a combination of lowdensity lipoprotein (LDL) and apolipoprotein (a), a homolog of plasminogen linked to each other by a sulfhydryl bridge. The concentrations of Lp(a) in human plasma vary from 0 to >300 nmol/l and appear to be principally under genetic regulation. Increased plasma Lp(a) has been shown to be an independent risk factor for some cardiovascular diseases, including abdominal aortic aneurysms (AAAs). 7, 8 However, to the best of our knowledge, very limited data is available on the association of Lp(a) and aortic dimension. 8 On the other hand, research has revealed an association between alcohol consumption and a lower risk for coronary heart disease, partly due to favorable lipid changes. 9 However, the relation between alcohol and aortic diameter remains largely unexplored. Therefore, the current study aimed to determine the association of heavy drinking, serum Lp(a) levels and lipid profile with infrarenal aortic dimension in patients with classic cardiovascular risk factors or clinically evident atherosclerotic disease.
Materials and methods

Study population
A total of 395 patients (238 males and 157 females, aged between 41 and 97 years, mean 66.6 ± 10.3 years) with clinically evident atherosclerotic disease or cardiovascular risk factors were recruited between January and December 2007. Study participants were selected consecutively from patients who were referred to our outpatient clinic for controlling of cardiovascular risk factors, including diabetes mellitus, hypertension and hyperlipidemia, or with atherosclerotic cardiovascular disease, including newly diagnosed coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral arterial disease (PAD), and the combined variables of any of these clinical manifestations.
The local research ethic committee approved the study protocol and all participants gave their informed consent.
Patients with any of the following conditions were excluded: connective tissue disease, congenital heart disease, cardiomyopathy, congestive heart failure, chronic renal dysfunction, liver dysfunction, rheumatic arthritis, secondary causes of hypertension, insulin-dependent diabetes mellitus, active inflammatory disease or active cancer. We also excluded individuals on lipid-lowering therapies. None of the participants was receiving drugs that could influence circulating Lp(a) levels, such as nicotinic acid, estrogens, progesterone or anabolic steroids. No age criteria were used to exclude.
CAD was identified as the diagnosis of angina pectoris or myocardial infarction. Patients with CVD had a transient ischemic attack or minor ischemic stroke. PAD was defined as a symptomatic and documented obstruction of distal arteries of the leg or surgery of the leg (percutaneous transluminal angioplasty, bypass or amputation). We used modified Asian criteria of the National Cholesterol Education Program Adult Treatment Panel III to define the presence of metabolic syndrome. 10 Diabetes was diagnosed according to the American Diabetes Association criteria. Arterial hypertension was diagnosed according to the World Health Organization criteria. Hyperlipidemia was defined by following the criteria of the ATP III Expert Panel of the US National Cholesterol Education Program.
Smoking status was defined as current, former, or never. Patients defined as smokers were those who had been smoking at least 10 cigarettes per day for at least 5 years. Cigarette smoking was calculated in pack-years (years of smoking multiplied by average number of packs smoked per day), with the value 0 entered for lifelong non-smokers. One gram of other smoking tobacco, such as pipe-tobacco, was considered equivalent to one cigarette. The amount of alcohol consumed was calculated according to the frequency of consumption and the alcohol concentration of beverages consumed. Heavy drinking was defined as average alcohol consumption ≥30 g/day. 11 Ultrasound evaluation B-mode ultrasound scanning was done to measure the maximal anteroposterior diameter of the infrarenal aorta by an experienced ultrasonographer using a Vivid 7 digital ultrasound system (GE Vingmed) equipped with a 3.5 MHz transducer. Detailed methods for abdominal aortic ultrasound evaluation were described previously. 5 Briefly, an ultrasound study of the abdominal aorta was performed using B mode in transverse and longitudinal projections. The infrarenal measurement was taken below the renal arteries at the site of maximum aortic artery diameter (adventitia plus wall). The reproducibility of the infrarenal aorta diameter measurements was evaluated in 25 patients within 1 week of the first ultrasonographic examination. The correlation coefficient for infrarenal aorta diameter was 0.97.
Laboratory studies
Antecubital venous blood samples were collected from all subjects after fasting overnight. Blood samples were obtained from patients before surgical or endovascular management. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), apolipoprotein AI (Apo AI), apolipoprotein B (Apo B), creatinine, uric acid, and fasting glucose concentrations were performed by commercially available standardized methods. Serum Lp(a) was measured with nephelometry (a method that depends on the measurement of the intensity of scattered laser light emanating from an illuminated volume of a dilute suspension of small particles) on the Olympus AU 2700 Clinical Chemistry analyzer, using reagents from Leadman (Sino-German Beijing Leadman Biotech Ltd) according to the manufacturer's instructions. The intra and inter-assay coefficients of variation were less than 5% and 7%.
Data analysis and statistical methods
An SPSS 11.5 software package was used for statistical analysis. Descriptive statistics of the study cohort were summarized by means and standard deviations for normally distributed continuous variables and medians and ranges for non-normally distributed continuous variables. The univariate associations between infrarenal aortic diameter and continuous study variables were evaluated with Pearson's correlation for normally distributed data, and Spearman's correlation for data that was not normally distributed. Partial correlations were calculated to adjust for age, sex and body size. Linear regression was used to evaluate the influence of sex, heavy drinking, metabolic syndrome, chronic obstructive pulmonary disease (COPD), antihypertensive therapy, hypertension, hyperlipidemia and diabetes on aortic dimensions. Finally, multivariable linear regression was used to determine the simultaneous significance of the associations between the risk factors and diameter of the infrarenal aorta. A standardized regression coefficient was used to represent increase or decrease in the outcome in standard deviation units per standard deviation increase or decrease in the predictors after adjusting for all the other variables in the model. Quartiles for LDL-C/HDL-C and Lp(a) were based on the distribution of the total population. Adjusted mean values for subject characteristics were calculated using general linear models. Age and sex-adjusted correlations between heavy drinking and lipid profile and Lp(a) were also determined using linear regression. A p-value <0.05 was considered to be statistically significant. Table 1 reports the baseline characteristics of the study population. The mean age was 66.6 ± 10.3 years, and 60.1% of patients were men. The mean infrarenal aortic diameter was 14.10 ± 2.57 mm.
Results
Aortic diameters were found to be positively associated with male sex (standardized β = 0.394, p < 0.00001), heavy drinking (standardized β = 0.265, p < 0.00001) and COPD (standardized β = 0.205, p < 0.00001). In addition, there were negative associations of abdominal aortic diameter with diabetes mellitus (standardized β = -0.196, p < 0.00001), metabolic syndrome (standardized β = -0.198, p < 0.00001), and hyperlipidemia (standardized β = -0.137, p = 0.006). No significant relationships were found between aortic dimensions and status of anti-hypertensive therapy (standardized β = 0.009, BSA, body surface area; BMI, body mass index; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoproteincholesterol. a Continuous data were presented as the mean value ± SD (range), except for lipoprotein (a), which were expressed as median (range); categorical data were presented as percentages. p = 0.681) and hypertension (standardized β = -0.067, p = 0.185). Table 2 presents the results of the correlations between continuous study variables and aortic adventitial diameter. Infrarenal aortic diameter was significantly associated with Lp(a) (r = 0.164, p = 0.001), HDL-C (r = 0.139, p = 0.006) and smoking (r = 0.104, p = 0.039) independent of age, sex, and height. With the same adjustment, a significantly negative relationship between abdominal aortic diameter and LDL-C (r = -0.161, p = 0.001), LDL-C/HDL-C (r = -0.216, p < 0.00001), and TC/HDL (r = 0.159, p = 0.002) were found. In multiple linear regression analysis (Table 3) , height (standardized β = 0.278), diastolic blood pressure (standardized β = 0.158), Lp(a) (standardized β = 0.166), heavy drinking (standardized β = 0.082) and COPD (standardized β = 0.112) were predictors of infrarenal aortic diameter (p < 0.05 for all). In contrast, LDL-C/HDL-C (standardized β = -0.202) and diabetes mellitus (standardized β = -0.103) were independent negative determinants of infrarenal aortic diameters (p < 0.05). The significance of the associations for these variables did not change in a model containing the same variables except replacing LDL-C/HDL-C with TC/HDL-C (standardized β = -0.139, p = 0.003) or LDL-C (standardized β = -0.161, p < 0.0001). Figure 1 shows the relationship between quartiles of Lp(a), LDL-C/HDL-C, and abdominal aortic diameter.
In addition, there was a negative association of LDL-C/HDL-C [coefficient (B) = -0.321, p = 0.026] and TC/HDL-C [coefficient (B) = -0.320, p = 0.037] and a positive association of HDL-C [coefficient (B) = 0.069, p = 0.031] and Apo AI [coefficient (B) = 0.111, p = 0.007] with heavy drinking, adjusting for age and sex (Table 4 ).
Discussion
Duplex ultrasound is commonly used to diagnose aneurysms of the abdominal aorta by measuring its diameter. The primary finding of the present study was that high serum levels of Lp(a) and heavy drinking were independently associated with larger infrarenal aortic diameters measured by ultrasound in individuals with classic CVD risk factors or clinically evident atherosclerotic disease. Moreover, among these high-risk patients, the infrarenal aortic diameter decreased with increments in LDL-C, and ratios of LDL-C/HDL-C and TC/HDL-C.
Elevations of Lp(a) concentrations in individuals with AAAs have been indicated by some studies. 7, 8 However, little data are available on the association between Lp(a) and infrarenal aortic diameter. In this paper, we document a linear correlation between Lp(a) plasma levels and abdominal aortic diameter independent of other risk factors. Lp(a) has been indicated to inhibit elastolysis by reducing activation of MMP-9 through the impaired generation of plasmin, which may prevent aortic dilatation due to other causes (e.g. genetic abnormalities of the aortic wall). 12 The physiologic role of Lp(a) has not been entirely determined yet. It has also been suggested to play a role in thrombus formation and reinforcement of the aortic wall in AAA disease. 13 Further studies on the influence of Lp(a) on aortic dimension and the underlying mechanism is warranted.
There is a general tendency towards atherosclerosis and arterial dilatation in older age, and hyperlipidemia also tends to increase arterial diameters. In the present study, multiple regression analysis demonstrated that LDL and ratios of TC/HDL and LDL-C/HDL-C were independent negative determinants of infrarenal aortic diameter. Although atherosclerosis in the abdominal aorta was reported to be associated with increasing abdominal aortic diameter, previous studies on the relation among AAAs, abdominal aortic diameters and serum lipid levels are contradictory. 5, 6, 14, 15 In a cross-sectional study on women aged 53.9 ± 2 years, a significant positive association of abdominal aortic diameter and TG was reported. 5 However, such a relation of lipid and aortic diameter could not be demonstrated in the study on a recent investigation of patients aged 57.8 ± 10.8 years. 6 An explanation for the discrepancy between the results of the present and previous studies may be the different patient selection. Our study participants had clinical atherosclerotic disease or cardiovascular risk factors and the mean age was 66.6 ± 10.3 years. The population in the above three studies, however, appeared to consist of younger and relatively healthier individuals. Also, we could not exclude the possibility that the roles of lipid profile in aorta dimension may differ across ethnic and racial groups.
Heavy drinking emerged as a predictor of infrarenal aortic diameter in our study. This result is consistent with a recent report that demonstrated a positive trend with the highest risk of AAAs among men who consumed >30 g/day of alcohol. 11 Some Heavy drinking, Lp(a) and lipid profile to infrarenal aortic diameter 327 studies have observed a decreased risk of CAD continuously up to the highest alcohol consumption, partly due to anti-atherogenic lipid changes. 9 In the present study, the positive association between heavy drinking and abdominal aortic dimension was independent of lipid profile as well as other risk factors, in spite of the negative relationship between LDL-C/HDL-C, TC/HDL-C, and heavy drinking. Therefore, alcohol may exert an unfavorable effect in the infrarenal aorta dilatation by more complex mechanisms. Pathologically, aneurysmal aortic disease is primarily a disease of the media, whereas occlusive atherosclerotic vascular disease is predominantly an intimal process. 16 So the association of alcohol with cardiovascular diseases may follow an occlusive versus non-occlusive (aneurysmal, other) pattern. Our findings are in agreement with a previous study that found sex and various measures of body size to be associated with aortic dimensions. 6 Unlike the finding in the same report, 6 the current study shows that age was not a significant determinant of aorta diameter, which was supported by another reported finding that the infrarenal aorta diameter increases only in a minority of the population. 4 Smoking was reported to be strongly associated with aortic diameter and risk of AAAs. 5, 6 Our study also showed that smoking was significantly associated with aortic diameter, independent of age, sex and height. Surprisingly, the strength of this relation could not be further demonstrated by multiple regression analysis, which may have been due to the relatively low incidence of smoking in our study population. Interestingly, lack of association between smoking and abdominal aortic diameter was reported in a recent study. 6 Our observation of the negative relationship between the incidence of diabetes mellitus and aortic diameter is in accord with a few other reports. 6, 14 Additionally a positive association of metabolism syndrome and abdominal aortic diameter reported by Gorter et al. 17 could not be demonstrated in the present study. The independent relationship between diastolic blood pressure levels and abdominal diameter in our study is consistent with some clinical studies reported. 5 According to our results, we speculated whether efforts to decrease atherogenesis by lowering LDL and Lp(a) may imply that increased risk of abdominal aorta dilatation and AAA formation. It has been shown that antilipid treatment with niacin or statins and aspirin could lower Lp(a) levels. [18] [19] [20] Therefore, we could not exclude the possibility that the decrease in the rate of deaths from arterial occlusive diseases accompanied by an increase of deaths from AAA may to some extent be related to the use of aspirin and antilipid drug therapy.
In conclusion, this study demonstrated a positive association of heavy drinking, Lp(a) and infrarenal aortic diameters. Furthermore, the novel and unexpected inverse association between LDL, LDL-C/ HDL-C, TC/HDL-C, and infrarenal aortic diameter suggests a possible role for anti-atherogenic lipid profile (characterized by a higher level of HDL-C and a lower level of LDL-C) in abdominal aortic dilatation processes, which need to be clarified by further studies.
It must be stressed, however, that these data are derived from a cross-sectional study and that our findings do not represent estimates of growth of the abdominal diameter with heavy drinking and change of Lp(a), LDL, LDL/TC, and LDL-C/HDL-C levels. Follow-up studies are needed to obtain such estimates.
